Optimal scheduling of radiotherapy and angiogenic inhibitors

Recommendations

Optimal combined radio- and anti-angiogenic cancer therapy
On optimal delivery of combination therapy for tumors
Optimizing the delivery of combination therapy for tumors: A mathematical model
Optimal solutions for a model of tumor anti-angiogenesis with a penalty on the cost of treatment
Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models

Cited in

(37)

Stability analysis of the family of tumour angiogenesis models with distributed time delays
Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy
Qualitative analysis of tumor growth model under antiangiogenic therapy -- choosing the effective operating point and design parameters for controller design
Optimal combined radio- and anti-angiogenic cancer therapy
Optimization of antitumor radiotherapy fractionation via mathematical modeling with account of 4 R's of radiobiology
Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method
Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics
Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments
Optimisation of cancer drug treatments using cell population dynamics
Optimizing chemoradiotherapy to target metastatic disease and tumor growth
On optimal delivery of combination therapy for tumors
Numerical solution for a problem arising in angiogenic signalling
Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function
Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers
Optimizing the delivery of combination therapy for tumors: A mathematical model
Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
On probabilistic certification of combined cancer therapies using strongly uncertain models
Analysis of anticancer efficiency of combined fractionated radiotherapy and antiangiogenic therapy via mathematical modelling
Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity
An optimal control approach for the treatment of solid tumors with angiogenesis inhibitors
Local controllability and optimal control for a model of combined anticancer therapy with control delays
On an extension of a mathematical model for tumor anti-angiogenesis
Analysis of the Hopf bifurcation for the family of angiogenesis models
Closed-loop control of tumor growth by means of anti-angiogenic administration
A bi-parametric model for the tumour angiogenesis and antiangiogenesis therapy
Tumor development under combination treatments with anti-angiogenic therapies
Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors
Mathematical model of cancer growth controled by metronomic chemotherapies
scientific article; zbMATH DE number 1910471 (Why is no real title available?)
Modelling pulsed immunotherapy of tumour-immune interaction
Optimal control of cancer treatments: mathematical models for the tumor microenvironment
Optimal control for a bone metastasis with radiotherapy model using a linear objective functional
Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruning
Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
What mathematical models can or cannot do in glioma description and understanding
Optimal control problems for differential equations applied to tumor growth: state of the art
On the role of pharmacometrics and the objective in optimizing cancer therapies

This page was built for publication: Optimal scheduling of radiotherapy and angiogenic inhibitors

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q253387)